| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | -0.025 | 0.6 |
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | BIRB 0796 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | 0.027 | 0.6 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | -0.025 | 0.6 |